Related Experiment Video
Updated: May 17, 2025

06:04
Author Spotlight: Studying Clinical Characters and Epilepsy Outcomes After Frontal Disconnection in Patients with MOGHE
Published on: August 16, 2024
694
Meningiomas-Related Epilepsy After Surgery
Francesca Battista1, Giulia Cultrera2, Cristina Andreea Aldea1,2
1Department of Neurosurgery, Careggi University Hospital, 50134 Florence, Italy.
Cancers
|May 14, 2025
Summary
Surgery effectively treats meningioma-related epilepsy (MRE). Peritumoral edema (PE) presence indicates better seizure resolution and aids in deciding when to stop antiseizure medications (ASMs) post-surgery.
Area of Science:
- Neurosurgery
- Epileptology
- Neuroradiology
Background:
- Meningioma-related epilepsy (MRE) affects approximately 30% of patients.
- Current research lacks clear guidelines on discontinuing antiseizure medications (ASMs) after surgical resection for MRE.
Purpose of the Study:
- To investigate the impact of surgical resection on MRE.
- To determine the role of peritumoral edema (PE) in MRE resolution and ASM discontinuation timing.
Main Methods:
- Retrospective analysis of 128 patients with supratentorial meningiomas who underwent surgical resection.
- Preoperative MRI used to quantify meningioma and peritumoral edema (PE) volumes.
- Analysis of epilepsy frequency pre- and post-surgery in relation to PE presence.
Main Results:
- Surgical treatment significantly reduced MRE from 41.4% to 19.5% (p=0.0001).
- Patients with preoperative PE showed a significant seizure reduction (45.3% to 18.9%, p=0.0002), unlike those without PE (p=0.24).
- ASM continuation was noted in 37.8% of Engel IA patients.
Conclusions:
- Peritumoral edema (PE) enhances the likelihood of MRE resolution following surgery.
- Surgical resection positively impacts MRE and ASM discontinuation, particularly when PE is present.
- PE serves as a key factor in guiding decisions about the timing of ASM discontinuation post-surgery.
More Related Videos
Related Concept Videos
Arteries of the Lower Limbs
173
Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
173
Seizures: Classification
292
Epilepsy is primarily characterized by unpredictable seizures, either provoked by an identifiable factor, such as injury or illness, or unprovoked, occurring spontaneously without apparent cause.
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
292
Antiepileptic Drugs: Glutamate Antagonists
261
Glutamate is a fundamental neurotransmitter in the central nervous system, playing a vital role in neuronal communication and various cognitive processes. Glutamate stands as the principal excitatory neurotransmitter in the brain. Its presence is crucial for the communication between neurons, underpinning essential processes such as synaptic transmission, neuronal excitability, and plasticity. These functions are vital for higher-order cognitive processes, including learning and memory. The...
261

